08:07 AM EDT, 07/18/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) reported Q2 adjusted earnings Thursday of $1.14 per diluted share, up from $1.08 a year earlier.

Analysts polled by Capital IQ expected $1.10.

Net sales for the quarter ended June 30 were $10.38 billion, compared with $9.98 billion a year earlier.

Analysts surveyed by Capital IQ expected $10.37 billion.

The company said it now expects fiscal 2024 adjusted earnings of $4.61 to $4.71 per diluted share, compared with $4.55 to $4.70 anticipated previously. Analysts surveyed by Capital IQ expect $4.63.

Q3 adjusted earnings are expected to fall in the range of $1.18 to $1.22 per diluted share, Abbott said. Analysts polled by Capital IQ expect $1.20.

The company also said its board on June 14 maintained its quarterly dividend at $0.55 per share, payable Aug. 15 to shareholders of record as of July 15.

Price: 104.77, Change: +0.09, Percent Change: +0.09